Article | May 16, 2022

EU's New Clinical Trial Regulation: What Does It Hold For Sponsors And Sites?

Source: OCT Clinical

The Clinical Trials Information System (CTIS) is a centralized platform for Clinical Trial Application (CTA) and marketing authorization submissions, and supervision of clinical trials across the European Union/European Economic Area (EU/EEA). The regulation, which came into effect on January 31, 2022, aims to simplify and streamline routine clinical processes.

The new regulation enables sponsors to submit one online application via the platform for approval to run a clinical trial in several EU countries, which makes it more efficient to carry out multinational trials. The same applies to other study documents, including main study documentation and country specific documents - everything is submitted centrally within CTIS.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader